Pro and anti-apoptotic cytokines and the incidence of apoptosis in newly diagnosed cases of myelodysplastic syndromes (MDS).

被引：0

作者：

Shetty, V ^{[1
]}

Allampallam, K ^{[1
]}

Hussaini, S ^{[1
]}

Mundle, S ^{[1
]}

Reza, S ^{[1
]}

Cartlidge, J ^{[1
]}

Broady-Robinson, L ^{[1
]}

Li, B ^{[1
]}

Huang, RW ^{[1
]}

Mazzoran, L ^{[1
]}

Mahmud, W ^{[1
]}

Broderick, E ^{[1
]}

Townsend, W ^{[1
]}

Yakoob, S ^{[1
]}

Gundroo, A ^{[1
]}

Mativi, B ^{[1
]}

Qawi, H ^{[1
]}

Lisak, L ^{[1
]}

Preisler, H ^{[1
]}

Raza, A ^{[1
]}

机构：

[1] Rush Presbyterian St Lukes Med Ctr, Rush Canc Inst, Chicago, IL 60612 USA

来源：

BLOOD | 1998年 / 92卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3664

引用

页码：160B / 160B

页数：1

共 50 条

[1] Leukemic progression in myelodysplastic syndromes (MDS) is associated with decreased apoptosis and a reduced ratio of pro- versus anti-apoptotic Bcl-2 related proteins.
Parker, JE
Fishlock, KL
Mijovic, A
Pagliuca, A
Mufti, GJ
BLOOD, 1997, 90 (10) : 2318 - 2318
[2] Apoptosis: A review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease
O'Brien, Mauria A.
Kirby, Rebecca
JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2008, 18 (06) : 572 - 585
[3] Effect of anti-phosphatidic drugs on the expression of cytokines in myelodysplastic syndromes (MDS).
Shetty, V
Dar, S
Hussaini, S
Alvi, S
Span, L
Mundle, S
Gezer, S
Gregory, S
Venugopal, P
Hines, C
Chopra, H
Borok, R
Robin, E
Rifkin, S
Alston, D
Hernandez, B
Hsu, WT
Preisler, H
Raza, A
EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 573 - 573
[4] Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients
Pease, Daniel F.
Ross, Julie A.
Poynter, Jenny N.
Nguyen, Phuong L.
Hirsch, Betsy
Cioc, Adina
Roesler, Michelle A.
Warlick, Erica D.
CANCER EPIDEMIOLOGY, 2015, 39 (02) : 222 - 228
[5] The clinical and biologic significance of apoptosis, macrophages and cytokines in 145 patients with myelodysplastic syndromes (MDS).
Allampallam, K
Shetty, V
Broady-Robinson, L
Hussaini, S
Broderick, E
Mundle, S
Reddy, P
Dar, S
Zaidi, A
Nascimben, F
Raza, A
BLOOD, 2000, 96 (11) : 359A - 359A
[6] 'Low risk' myelodysplastic syndrome (MDS) is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic Bcl-2 related proteins.
Parker, JE
Fishlock, KL
Mijovic, A
Pagliuca, A
Mufti, GJ
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 105 - 105
[7] SYMPTOM BURDEN OF PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) RECEIVING OUTPATIENT CANCER CARE
Desai, A. V.
Goldberg, J. I.
Anderson, K.
Ranaghan, C.
O'shea, D.
Chow, K.
Kramer, D.
Rawlins, R.
Wan, P. J.
Klimek, V. M.
Nelson, J. E.
LEUKEMIA RESEARCH, 2017, 55 : S128 - S128
[8] Leukocyte apoptosis and pro-/anti-apoptotic proteins following downhill running
Park, Kyung-Shin
Sedlock, Darlene A.
Navalta, James W.
Lee, Man-Gyoon
Kim, Seung-Hwan
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2011, 111 (09) : 2349 - 2357
[9] Leukocyte apoptosis and pro-/anti-apoptotic proteins following downhill running
Kyung-Shin Park
Darlene A. Sedlock
James W. Navalta
Man-Gyoon Lee
Seung-Hwan Kim
European Journal of Applied Physiology, 2011, 111 : 2349 - 2357
[10] CLINICIAN UTILIZATION OF THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS) FOR NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
Pease, D.
Ross, J.
Poynter, J.
Nguyen, P.
Hirsch, B.
Cioc, A.
Roesler, M.
Warlick, E.
LEUKEMIA RESEARCH, 2015, 39 : S118 - S118

← 1 2 3 4 5 →